Carole Neuchterlein
@caroleneuchterlein
Director
Building Lysosomal Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Lysosomal Therapeutics, Inc. was founded in 2011 and has no closure on record.
Named alongside
- Brian DowdExecutive Vice President - Controller
- Bridget Ann MartellDirector
- Bridget Peter MartellDirector
- Carole Ann NuechterleinDirector
- Carole Peter NuechterleinDirector
- Hardean Peter AchneckExecutive Officer
- Heather Peter PrestonDirector
- Jack Ann NielsenDirector
- Carol C. GallagherDirector
- Carol GallagherDirector
- Christopher SeiterExecutive Officer
- James C. TopperDirector
- James HindmanDirector
- James TopperDirector
- Jeffery BrinzaExecutive Officer
- Julia C. OwensExecutive Officer, Director
At Lysosomal Therapeutics, Inc.
- Bernard DavitianDirector
- Bruce BoothDirector
- Bruce L BoothDirector
- Carole E. NuechterleinDirector
- Carole NuechterleinDirector
- Clay E. ThorpDirector
- Clay ThorpDirector
- Cornelis BeenExecutive Officer, Director
Contribution
Carole's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Lysosomal Therapeutics, Inc.Director · Biotechnology · CAMBRIDGE, United States · Founded 2011
- Atterocor, Inc.Pharmaceutical Preparations; formerly Atterocor, Inc.; filing with the SEC since 2012Director · Pharmaceuticals · ANN ARBOR, United States · Founded 2012
- Aligos Therapeutics, Inc.Biological Products, (No Diagnostic Substances); listed on Nasdaq as ALGS; filing with the SEC since 2020Director · Biotechnology · South San Francisco, United States